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Abstract
Maintenance of the homeostasis of zinc (Zn) is very important in regulating bodily
functions. There are over 300 Zn dependent enzymes identified, where Zn plays a structural
or catalytic role. However, an excess of Zn in a cell is toxic and free Zn ions are tightly
controlled. Metallothioneins (MTs) are small cysteine rich proteins, which can bind up to
seven Zn ions and act as a Zn reservoir. The MT2a isoform is predominantly found in the
liver. My research focused on the overexpression of human MT2a in Escherichia coli and
the investigation of Zn binding pathways of MT2a in vitro. At physiological pH, Zn is
terminally bound to the cysteine thiols of MT2a, making bead-like structures (noncooperative metal binding), while at low pH, Zn formed clusters bridging the terminally
bound Zn (cooperative metal binding). These findings draw our attention to investigate
how other essential and toxic metals bind to MT2a.
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Chapter 1
Introduction
1.1 Essential and toxic metals
All living organisms utilize metals. Some metals such as iron (Fe), zinc (Zn), copper
(Cu), magnesium (Mg) and cobalt (Co) are essential and are involved in a myriad of
biological functions.1-3 Metals such as lead (Pb), cadmium (Cd), mercury (Hg), and arsenic
(As) are toxic to cells.1, 2 Zinc is the second-most abundant essential trace element in the
human body, at 2.3 g in an average human weighing about 70 kg (Fe is the most abundant;
4 g in an average human), and is required for the function of many proteins.4,
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The

concentration of Zn(II) in an eukaryotic cell is very high (10-4 - 5×10-4 M) compared to
other essential metals and the cytosolic free Zn(II) concentration must be controlled within
a narrow range (within 10-5 M to 10-12 M).6-10 Metallothionein (MT) exists in the cytoplasm
and has the ability to bind essential and non-essential metals in the cell.6, 11
Most toxic metals such as Hg, Cd, Pb, and As are sulfhydryl-reactive metals, and
can bind to the sulfhydryl groups of proteins and disrupt their function.12 For example,
Jacobson et al.13 reported that As(III) causes misfolding and aggregation of Hsp104p-GFP
protein in Saccharomyces cerevisiae. Mercury and Cd have a high affinity for glutathione
(GSH), which is one of the primary antioxidants in the cytosol that protects the body against
oxidative and free radical damage.14, 15 Another metal binding protein that has been shown
to bind to metals using its sulfhydryl groups is MT, which forms metal-thiolate complexes
and protects other proteins from dysfunction.12 In this thesis, I am going to evaluate how
Zn binds to MT.

2

1.2 Biological role of zinc
Zinc contains a filled d orbital (d10); therefore, it is not involved in redox reactions
and functions only as a Lewis acid.4, 16, 17 This makes Zn a good metal cofactor for enzymes
that need redox-stable ions for biological reactions.4,

8

Zinc plays a key role in

deoxyribonucleic acid (DNA) synthesis, ribonucleic acid (RNA) transcription, cell
proliferation and activation, as enzymes such as RNA polymerase, DNA polymerase and
transcription factor IIIA are Zn metalloenzymes.18-20
Zinc is also involved in cell signalling.9 Zn can be found in glutamate-zinc releasing
neurones and neuronal somata that consist of Zn permeable gated channels, as well as all
calcium channels that are permeable to Zn.21 Kim et al. 22 revealed that Zn is needed for
maturation of mammalian oocytes and the total Zn in an oocyte was higher than the total
Fe or Cu. However, excess Zn in biological systems influences

misfolding

and

aggregation of Zn proteins and leads to intermolecular protein-protein interactions.16
1.2.1 Homeostasis of zinc
The importance of Zn homeostasis was deeply considered in 1958, after reporting
an

Iranian

patient

with

severe

growth

retardation,

anemia,

hypogonadism,

hepatosplenomegaly, mental lethargy, geophagia, and rough and dry skin.23,

24

These

symptoms arise from Zn deficiency. Consumption of only cereal proteins and no meat
products caused Zn deficiency for Middle Eastern and people from developing countries.19
If dietary intake of Zn is reduced, intestinal Zn absorption increases and Zn excretion
decreases.25 Although the body has these mechanisms to protect against Zn deficiency, it
cannot function properly with chronic deficiency.
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It is important to control the efflux and influx of Zn to maintain Zn homeostasis in
the cell.19 Zinc is transported from blood to cells through cell membrane transporters and
its concentration is tightly regulated by two families of transport proteins embedded in the
cell membrane: Zn transporters (ZnT) that remove Zn from the cell to the blood, and Zrtand Irt-like proteins (ZIP) that take up Zn from the blood.26-28 Maintaining low
concentrations of free Zn ions in the cytosol is important for health; concentrations have to
be low enough to avoid toxicity, but high enough to provide adequate Zn for cellular
function.
1.2.2 Zinc Proteins
In eukaryotic cells, Zn-dependent proteins are mainly found in the cytosol and
organelles such as the nucleus, mitochondria, Golgi apparatus, endoplasmic reticulum and
secretory vesicles.29 More than 3000 Zn proteins have been identified and more than 300
of these are Zn-containing enzymes, where Zn plays a catalytic or structural role.5, 30 Some
Zn-containing enzymes, such as carbonic anhydrase and carboxypeptidase, have one Zn
atom in their active site.5 Alcohol dehydrogenase is another example of a Zn-containing
enzyme; in it, Zn plays a structural and catalytic role in the same protein. Each of the two
subunits of alcohol dehydrogenase contains a structural Zn atom as well as another Zn atom
in their respective catalytic site.31 Asparate transcabamylase, an enzyme in Escherichia coli
(E. coli), has six Zn atoms, one in each of its six subunits; Zn plays only a structural role
in this enzyme.5, 32
Metal-responsive transcriptional factor-1 (MTF-1) consists of six Zn fingers and is
responsible for embryonic liver development and metallothionein biosynthesis.33 Zinc
plays a structural role in Zn fingers; these small proteins have Zn in their core and interact
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with nucleic acids, proteins and small molecules to control transcription and translation.34
Typical Zn fingers have Cys2His2 domains, and the Cys-Cys-His-His motif coordinates to
Zn in a tetrahedral geometry.35
There are 15 known ZIP proteins and nine ZnT proteins found in humans.25 Zrt-and
Irt-like proteins have eight transmembrane domains and a long histidine-rich loop between
domains three and four.29 ZnT however, has six transmembrane domains; the long histidine
rich loop is located between domains four and five.29 Metallothioneins bind free Zn in the
cell and act as Zn donors to Zn proteins such as carbonic anhydrase, resulting in low levels
of free Zn in the cytosol.26 Bidirectional Zn transfer has been seen between holometallothionein to apo-Zn proteins and from holo-Zn proteins to apo-metallothionein,
which clearly portrays the zinc donor-acceptor role of MT.36
1.3 Metallothioneins
Metallothioneins are low molecular mass (6-8 kDa), ubiquitous, and cysteine-rich
proteins, first isolated from horse kidney cortex in Cd-binding protein studies.37-39
Metallothioneins exist in all animal phyla, vascular plants, as well as some prokaryotes.40
Detoxification of heavy metals, homeostasis involving essential metals such as Zn and Cu,
and protection against oxidative stress in cells system are among the main processes
proposed to involve MTs.38, 40, 41 These activities arise from the properties of the metallated
protein.
1.3.1 Human metallothioneins
There are four isoforms of human MTs (Fig. 1): MT1 and MT2 are the major
isoforms of MT, which are found predominantly in the kidneys and the liver, as well as in
other tissues; MT3 and MT4 are minor isoforms of human MTs, which are seen only in
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unique tissue types such as the brain and the central nervous system, and squamous
epithelia, respectively.28,

42

A single gene encodes each type of MT2, MT3 and MT4

whereas a set of at least 10 MT1 genes encode the multiple sub types of MT1: MT1A,
MT1B, MT1E, MT1F, MT1G, MT1H, MT1J, MT1K, MT1L and MT1X.43-45
(β Domain: Residues 1-31)
MT1a–MDPN-CSCATGGSCTCTGSCKCKECKCTSCKK
MT2a-MDPN-CSCAAGDSCTCAGSCKCKECKCTSCKK
MT3 -MDPETCPCPSGGSCTCADSCKCEGCKCTSCKK
MT4 -MDPRECVCMSGGICMCGDNCKCTTCNCKTYWK
(α Domain: Residues 32-68)
MT1a-SCCSCCPMSCAKCAQGCICKG------ASEKCSCCA

61

MT2a-SCCSCCPVGCAKCAQGCICKG------ASDKCSCCA

61

MT3 -SCCSCCPAECEKCAKDCVCKGGEAAEAEAEKCSCCQ

68

MT4 -SCCPCCPPGCAKCARGCICKG------GSDKCSCCP

62

Figure 1. Cysteine alignments of human MT isoform sequences. Both the β domains (Top)
and the α domains (Bottom) are shown. The cysteines are highlighted in yellow and
different amino acid residues between MT1a and MT2a are highlighted in red. The extra
amino acid residues of MT3 and MT4 are highlighted in pink and green, and blue. The
figure is modified from Zalewska et al.38

MT1 and MT2 are more similar to each other than to MT3, which contains an extra
threonine in the β domain and an extra Gly-Glu-Ala-Ala-Glu-Ala motif in the α domain.
This hexapeptide motif forms an unordered loop in the C-terminus of MT3.46 MT4 has an
extra glutamic acid in the β domain. MT4 has eight cysteines in the β domain while all
other isoforms have nine cysteines.
Metal binding of MT3 is significantly different from MT1 and MT2 metal binding
because it has a lower metal binding affinity and metals bind non-cooperatively.46 The
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sequence differences of MT3, compared to MT1 and MT2, might be the reason for the
metal binding differences.
1.3.2 Structure of human metallothionein
Metallothionein is a monomeric protein with 61-68 amino acid residues of which
up to 20 are cysteines.47 Metallothionein has two independent metal binding domains: the
N-terminal β domain has 9 cysteine residues that coordinate 3 divalent metal ions such as
Cd, Zn and Co, and the C-terminal α domain has 11 cysteine residues that coordinate 4
divalent metal ions (Fig. 2).48 Metallothioneins bind to monovalent and trivalent metals as
well. Monovalent Cu (I) form Cu6S11 and Cu6S9 clusters in the α and β domains
respectively.49 Trivalent As (III) strongly binds to cysteines, forming an As3S11 cluster in
the α domain and an As3S9 cluster in the β domain.50 However, the two domains differ in
many ways; for metal binding, Cu preferentially binds to the β domain whereas Cd
preferentially binds to the α domain.51 Moreover, the addition of excess Cd leads to the
formation of supermetallated MT; which means that MT can bind up to eight Cd, forming
a superdomain.47
The thiol groups of the cysteine residues form mercaptide bonds with metals,
resulting in metal-thiolate clusters (Fig. 2).40 For example, four sulfur atoms bind to Zn(II)
in a tetrahedral coordination while three sulfur atoms bind to Cu (I) in a trigonal
coordination.48,

51

The 20 cysteine residues occur in three different arrangements

throughout the protein: Cys-Cys, Cys-X-Cys, and Cys-X-Y-Cys, where X and Y are amino
acid residues other than cysteine (Fig. 3).40 Disulfide bonds do not form between cysteine
residues and there are no aromatic amino acids in the protein.48
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Terminal thiol

Cd3-β Domain

Bridging thiol

Cd4-α Domain

Figure 2. Molecular model structures of human metallothionein 1a. Left side shows the β
domain and right side shows the α domain of Cd7-βαMT. Entire MT protein is shown in
A & B, and the individual domains are shown in C. (A) space filling (B) ball and stick
with space filling (C) ball and stick of Cd3-β and Cd4-α domains showing the Cd-thiolate
cluster formation of MT (one cysteine (yellow) bound to more than one Cd (green)
formed clusters). The terminal thiols and the bridging thiols of cysteines are indicated.
The figure is adapted from Sutherland & Stillman.52
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Figure 3. The sequence of human metallothionein 2a with S-tag (blue). Seven divalent
metals (green) bind to 20 cysteines (yellow). The cysteines are numbered 1-20.
Modifications to the N-terminus (MGKAAAA) and the C-terminus (KKAAAA) are shown
in pink. The thrombin cleavage site is indicated.
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1.3.3 The origin and biosynthesis of human metallothionein
Metallothionein can be found in the cytoplasm, nucleus, mitochondria and
lysosome.51, 53 Metallothioneins function both intra and extracellularly.51 For example,
MTs can be found in extracellular fluids such as plasma, urine, pancreatic fluid, amniotic
fluid, bile and milk.38, 51, 54 Protecting the DNA from oxidative damage or supplying Zn(II)
to Zn enzymes and transcription factors are the suggested roles of MT in the nucleus.53
Because MT1 and MT2 are expressed in many cell types in various organs, cell
signaling molecules like cytokines, and hormones like glucocorticoids, as well as a variety
of stress conditions such as reactive oxygen species, and metal ions induce their
biosynthesis but there is no evidence of biosynthesis of MT3 or MT4 from these
inducers.55-58 Moreover, MT3 is abundant in non-Zn-containing neurones such as
pyramidal neurones.59
Transcription of the MT gene is activated by MTF-1, by injection of a metal load
including Cd, Zn, Cu, Hg, and bismuth (Bi) to the body.33, 51 MTF-1 is a Zn finger protein,
consisting of six Zn fingers, and binds to metal response elements (MREs) with a core
consensus sequence TGCRCNC in the promotor of MT genes.33, 60, 61 Inhibition of MT
synthesis occurs at the transcriptional and translational level in the cell, by inhibitors such
as cycloheximide, actinomycin D, and puromycin.51
1.3.4 Zinc-metallothionein vs cadmium-metallothionein
Human Zn-metallothionein (Zn-MT) and Cd-metallothionein (Cd-MT) exhibit
similar physical and chemical properties, but the biological roles of the two proteins are
vastly different.48 Zn-MT is synthesized predominantly in the intestine and the liver to
regulate the homeostasis of Zn, while Cd-MT forms to protect against Cd toxicity by
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storing Cd in the liver, and later in the proximal tubular cells of the kidney cortex after
detoxification.62, 63 Cherian62 found that rats injected with Zn-MT did not show any toxic
effect because Zn-MT transferred the Zn(II) to other Zn proteins. In addition, in order to
protect highly Cd-sensitive organelles like nuclei and mitochondria from Cd toxicity, MT
initially sequesters Cd in the cytosol of hepatocytes in the liver.64
Even though we can induce Cd7-MT by supplying more Cd(II) to animals, native
MT proteins consist of Cd5Zn2-MT; four Cd(II) bind to the α domain making a stable
cluster, and one Cd(II) and two Zn(II) bind to the β domain making a less stable cluster.56
The two Zn atoms in the β domain are exchangeable.5 However, once MT is saturated with
Zn(II) or Cd(II), MT is not susceptible to degradation by proteases.56
1.3.5 Metallothioneins in human diseases
Some diseases show elevated or decreased levels of all or some isoforms of MT.
Significant increases of MT have been seen in patients with pancreatitis due to an increase
in free radical activity, and a decrease in free radical scavengers, such as superoxide
dismutase, catalase, glutathione peroxidase, vitamin E and C.53 Patients with Alzheimer’s
disease show a significant decrease of MT3 in their brain, the major isoform found in the
brain and central nervous system.65 Patients with neurological diseases such as Alzheimer’s
disease, Pick’s disease, Creutzfeldt-Jacob disease, amyotrophic lateral sclerosis, and
multiple sclerosis show elevated levels of MT1 and MT2 in their brain.65
There is a direct relationship between cancer cell proliferation and overexpression
of MT in the following cancers: squamous cell carcinoma of the esophagus, thyroid cancer,
uterine cervical squamous tumor, ovarian cancer, breast cancer, and nasopharyngeal
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cancer.44, 66, 67 Jin et al.

66

have shown that MT2 mRNA levels are higher than MT1 in

breast cancer tissues. However, MT1b is absent in breast cancer tissues.44
1.4 Metallation and metal binding affinity of metallothionein
Metal-dependent protein folding is characterized by the coordination of one or more
metal ions by the protein to give its fully functional conformation.11 One good example of
metal-dependent protein folding is the Cd-dependent folding of MT (Fig. 4). In vitro, the
binding affinity of metal ions to mammalian MTs shows the following order: Zn(II) <
Pb(II) < Cd(II) < Cu(I), Ag(I), Hg(II), Bi(III).38 Metallothioneins show a higher affinity for
Cd(II) than Zn(II), such that even Cd scarcely dispersed in the environment will result in
Cd accumulation in MTs.40 The binding constant of Cd7-MT2a is 3.2 × 1017 M-1 at pH 7.4
whereas the binding constant of Zn7-MT2a is 3.2 × 1013 M-1 at pH 7.4.36 Although toxic,
the 10,000 times greater binding affinity of Cd(II) for MT compared with Zn(II) means that
ingested Cd(II) will displace Zn(II) in Zn-MT.40

β Domain

A

D

α Domain

β Domain

B

C

α Domain

Figure 4. Metal-dependent protein folding of metallothioneins in vitro. (B) Red circles
represent Cd ions, which induce the synthesis of MT. (C) Metallation starts in the α domain
binding up to four Cd, then the β domain. (D) Seven Cd ions bind to MT; the α domain
consists of four Cd and the β domain consists of three Cd.
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1.4.1 Cooperativity
Cooperativity can be seen in many biological systems and can be explained in many
ways. Cooperativity describes how the binding of the first ligand to a receptor influences
the binding of subsequent ligands.68 Metal binding can be divided into three groups;
positive cooperativity, negative cooperativity, and non-cooperativity.68 In positive
cooperative metal binding, the equilibrium constant (K) for each subsequent ligand
increases with the addition of a metal, which facilitates the next metal ion binding.11 A
well-known example of positive cooperativity is the binding of oxygen molecules to
hemoglobin.69, 70 Binding of the first oxygen molecule increases the affinity of the protein
for a second oxygen molecule, then the third and fourth molecules as well.68 In nature, only
deoxygenated hemoglobin or oxygenated hemoglobin can be observed because
intermediates will not have resulted in extreme positive cooperativity.71,

72

When the

binding of one ligand interferes with the binding of the subsequent ligands to the protein,
the binding constant is lowered and this is called negative cooperativity.71, 73 The binding
of insulin to its receptor shows negative cooperativity.73-75 If subsequent binding events
have identical K values, it is called non-cooperative binding.68
Allosteric cooperativity occurs when the interaction of a ligand with a protein
changes the conformation of the protein.76 The phenomenon of i3 cooperativity is derived
from allosteric cooperativity and displays the following characteristics: binding of a ligand
induces the conformation of the multi-subunit protein, the conformational changes are
intramolecular, and the binding sites are identical to one another.76
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1.4.2

Proposed metallation pathways for metallothionein

There are two proposed metallation pathways for human metallothioneins: cooperative
and non-cooperative.77 The cooperative metal binding pathway of MT is not quite the same
as the cooperative protein-ligand interactions discussed in section 1.4.1. For MT, the metals
bind to terminal thiols and then form stable metal clusters through bridging thiols; this
phenomenon is the cooperative metal binding pathway of MT (Fig. 5).

47, 77

Terminally

bound intermediates are less dominant in this pathway.47, 77 Vasak & Kagi78 have shown
that the first four Co ions bind to terminal thiols of rabbit liver metallothionein 1 in a
tetrahedral geometry prior to the formation of Co-thiolate clusters. When divalent metals
bind to the seven metal bindings sites on MT, metal binding starts at the α domain in a
cooperative manner, forming a stable cluster, whereas the β domain follows the cooperative
manner but forming a less stable cluster.56, 79, 80 However, demetallation follows the reverse
order of metallation; the β domain releases its metals prior to the α domain.56, 81
Non-cooperativity occurs when one metallation event does not facilitate the subsequent
metallation events.52 Each metallation event happens independently at each domain.52 In
the non-cooperative metal binding pathway of MT, metals bind to terminal thiols and make
bead-like structures (Fig. 5).47,

77, 82

The four metal clusters are less dominant in this

pathway; the intermediates can be seen and metal speciation shows a normal distribution.77
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5Zn
+2Zn

+4Zn

Cooperative
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Figure 5. Two proposed metallation pathways of MT for divalent metals; Zn(II) binding
to MT2a is used as an example. The cooperative (cluster formation) pathway is shown
following pink arrows (D & E) and non-cooperative (beads formation) pathway is shown
following blue arrows (B & C). In the non-cooperative pathway, 20 cysteine residues are
terminally bound to five metals, and the 6th and 7th metal bind to form two stable clusters.
In the cooperative pathway, four metals bind to 11 cysteine residues forming a stable M4S11
cluster (D) and then three metals bind to nine cysteine residues forming two stable clusters
(F). The intermediates (Zn1-MT2, Zn2-MT2 and Zn3-MT2) are dominant in the spectrum
is shown at top (beads formation) and clusters (Zn4-MT2) are dominant in the spectrum is
shown at bottom (cluster formation). The figure is modified from Irvine et al.77
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1.4.3

pH and metallothionein
The intrinsic pKa of cysteine is 8.6 and positively charged residues will lower the

pKa, whereas negatively charged residues will raise the pKa of the cysteine.83 Below the
pKa of cysteine, metals compete with protons.48, 84 Due to the high proton content at low
pH, metals compete with protons to bind to MTs and form bridges between terminal thiols
resulting in metal-thiolate stable clusters.77 At high pH, competition of metals and protons
to MT thiols are less intense due to lower proton content in the environment and metals
still bind to terminal thiols of MTs, but cluster formation is not dominant.77 Therefore,
protons influence the metallation of MTs in vitro. This is similar to the binding of oxygen
to hemoglobin in the human, where the binding affinity of oxygen is influenced by protons,
organic phosphates, chlorides and carbon dioxide.85
1.5 Hypothesis
Because metal binding reactions are dependent on the exact amino acid sequence
of the protein, I hypothesize that metallation will differ between the liver MT2a and the
kidney MT1a. I think that non-cysteine amino acids in the MT2a and MT1a influence the
metal binding properties of Zn.
I predict that at low pH, MT2a will show a cooperative metal binding pathway
whereas at physiological pH, MT2a will show a non-cooperative metal binding pathway.
Low pH destabilizes the formation of individual bead-like structures and favours the
formation of clusters.

16

1.5.1 Objectives of this research
One goal of this research was to overexpress human MT2a in E. coli, which is a
very difficult protein to express in E. coli and the Stillman group has been trying to express
this protein for several years.
My second objective was to determine the pathways of Zn(II) binding to MT2a
with changing pH, monitored using Electrospray Ionization Mass Spectrometry (ESI-MS).
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Chapter 2
Materials and Methods
2.1 Modifications to the MT2a sequence
Expression studies were conducted using the MT2a sequence previously generated
by the Stillman lab. (The MT2a sequence, with the S-tag without modifications to the N
and the C-termini, is shown in Figure 3). A series of test expressions were carried out to
identify the optimal isopropyl-β-D-1-thiogalactopyranoside (IPTG) concentration (0.1-5
mM) and optimal temperature (16°C, 20°C, 30°C and 37°C) for maximum yield of MT2a.
The pET 29a plasmid with the MT2a gene was transformed to the following cell lines:
BL21 (DE3), BL21 C+, Rosetta 2, BLR pLysS, Nova Blue (DE3), Rosettablue pLysS,
Tuner pLysS, BLR (DE3), B834 pLysS and BL 21 pLysS. The MT2a gene was cloned into
the pGEX-6p2 vector with the GST tag. Low yields were obtained for the expression of
MT2a and the yield could not be optimized using common techniques due to the instability
of the protein. Therefore, further details of these expression studies were not included in
this thesis.
An MT2a gene within the pET29a plasmid in BL21 (DE3) cells was poorly
overexpressed and MT2a yield was too low to carry out experiments using ESI-MS. A new
MT2a sequence was designed by adding amino acids to the N-terminus (MGKAAAA) and
the C-terminus (KKAAAA) (Fig. 3). The DNA sequence of MT2a was synthesized and
cloned into the pET29a plasmid using restriction enzymes, Ncol and Hindlll completed by
GENEWIZ (South San Francisco, CA 94080, USA). The resulting protein with the S-tag
is shown below. The S-tag is highlighted in blue, extra amino acid residues added to the N
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and C termini are highlighted in red and the native human MT2a protein sequence is in
bold font:
MKETAAAKFERQHMDSPDLGTLVPRGSMGKAAAAMDPNCSCAAGDSCTCAG
SCKCKECKCTSCKKSCCSCCPVGCAKCAQGCICKGASDKCSCCAKKAAAA
2.1.1 Solutions and agar plates preparation
The 50 mg/mL kanamycin antibiotic was prepared by adding 0.5 g of kanamycin
powder into 10 mL of deionized water (DI water). The 1 M IPTG solution was prepared
by dissolving 2.38 g of IPTG solid in 10 mL of DI water. Both solutions were filtered using
a 0.2 µm syringe filter and stored at -20°C. 1 M cadmium sulfate (CdSO4) was prepared
by dissolving 5.13 g of CdSO4 solid in 20 mL DI water and stored at room temperature.
Lysogeny broth (LB) agar (Miller) was prepared by dissolving 10 g of LB agar in
250 mL water, then the solution was autoclaved at 121°C for 15 minutes. After the liquid
cooled to room temperature, 250 µL of the kanamycin solution was added and the mixture
quickly poured into 10 sterile Petri dishes, and left at room temperature for 30 minutes
(The final concentration of kanamycin in the agar plates was 50 µg/mL). After the agar in
the Petri dish hardened, it was stored at 4°C. Regular LB agar plates were prepared
following the same method without the addition of kanamycin and stored at 4°C.
Liquid LB media (Miller) for bacterial pre-cultures was prepared by dissolving 2.5
g LB into 100 mL DI water. Growth media for bacteria was prepared by dissolving 25 g of
LB media in 1 L of DI water. A 4L of LB media was prepared. All liquid LB media were
autoclaved at 121°C for 15 minutes and stored at room temperature.
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2.1.2 Making competent cells
Competent cells, TOP20 and BL21 (DE3), were prepared by following method: the
TFB1 buffer was made by mixing 30 mM potassium acetate (CH3CO2K) (1.472 g), 10 mM
calcium chloride (CaCl2) (0.555 g), 50 mM manganese chloride (MnCl2) (4.948 g), 100
mM rubidium chloride (RbCl2) (6.046 g) and 15% glycerol in 425 mL DI water. The pH
was adjusted to 5.8 and 75 mL of glycerol was added to the solution. The TFB2 buffer was
made by mixing 10 mM 3-(N-morpholino) propanesulfonic acid (MOPS) (1.046 g), 75
mM CaCl2 (4.162 g), 10 mM RbCl2 (0.604 g), and 15% glycerol in 425 mL DI water. The
pH was adjusted to 6.5 and 75 mL of glycerol was added to the solution. Both buffers were
stored at 4°C.
Both TOP10 and BL21 (DE3) cells were plated on agar plates (without antibiotics)
and incubated over night at 37°C. The next morning, one colony of each cell types was
transferred into 25 mL LB medium and the cells were grown at 37°C using a shaker
(Excella E24 incubator shaker series, New Brunswick Scientific) at 175 RPM, until an
optical density (OD) of 0.6 (600 nm) was reached. Cells were harvested by centrifugation
(Beckman Coulter, Avanti J-26 XPI) at 6000 RPM for 15 minutes at 4°C. After removing
the supernatant, 10 mL of TFB1 buffer was added to the cell pellets and incubated on ice
for 5 minutes. The cell mixture was then centrifuged again for 5 minutes at 3000 RPM at
4°C and the supernatant was removed. A 400 µL aliquot of the TFB2 buffer was added to
each tube and incubated on ice for 30 minutes. The competent cells were divided into 40
µL aliquots and stored at -80°C.
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2.1.3 Transformation of pET29a plasmid with MT2a gene into E. coli
Lyophilized pET29a plasmids including the MT2a gene were mixed with 40 µL of
autoclaved DI water. A 2 µL aliquot of plasmid mix was added into 40 µL competent
TOP10 E. coli cells and subjected to a 42°C heat shock for 45 seconds. Immediately after
the heat shock, the cells were cooled on ice for 2 minutes. Afterwards, 1 mL of preheated
LB medium was added to the TOP10 cells and incubated at 37°C for 60 minutes.
Transformed TOP10 cells were plated on LB agar plate with kanamycin (50 µg/mL), and
incubated overnight at 37°C. The next morning, one colony was transferred to 10 mL LB
medium with 10 µL kanamycin (50 mg/mL) and grown on a shaker at 175 RPM at 37°C
until it reached the target OD600. The plasmids were extracted using a PrestoTM mini
plasmid kit (Geneaid) as per the manufacturer’s instructions. A 2 µL aliquot of extracted
plasmids were transformed into BL21(DE3) competent cells using the above protocol.
BL21 (DE3) cells were plated to an LB agar plate with kanamycin (50 µg/mL) and
incubated overnight at 37°C. One colony was transferred to 10 mL LB media with 10 µL
of kanamycin (50 mg/mL) and grown on a shaker at 175 RPM at 37°C until it reached the
target OD600. Glycerol stocks were made to store the cells in a -80°C freezer. A 650 µL
aliquot of cell culture was transferred into autoclaved 1.5 mL Eppendorf tube and mixed
with 350 µL 80% autoclaved glycerol.
2.1.4 Overexpression of metallothionein 2a in E. coli
To make the pre-cultures, 100 mL of autoclaved LB medium was transferred into
each of 4 Falcon tubes after adding 100 µL of kanamycin (50 mg/mL). The four precultures were inoculated by 1 µL of glycerol stock, which included the E. coli with pET
29a plasmid carrying the MT2a gene, to each tube. The four pre-cultures were incubated
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overnight at 37°C in the shaker at 100 RPM. The next morning, the pre-cultures were
transferred into four autoclaved flasks with 1 L LB medium, 1000 µL kanamycin (50
mg/mL) and 50 µL 1 M CdSO4. All four cultures were incubated in the shaker (175 RPM)
at 37°C. BL21 (DE3) cells with the MT2a gene were grown until they reached the target
OD600. It took approximately four hours to reach the OD600. Then, 600 µL of 1 M IPTG
was added to each flask to induce protein expression. After half an hour of induction, 150
μL of 1 M CdSO4 was added to the LB media to aid the proper folding and stabilization of
MT2a and the cells were left to grow for three hours. Cells were harvested by centrifugation
(Beckman Coulter) at 6000 RPM for 15 minutes at 4°C. After removing the supernatant,
cell pellets were stored at -80°C.
2.1.5 Purification and cleavage of S-tag
For purification, 10 mM Tris-hydroxymethyl-aminomethane (Tris-HCl) and 10
mM Tris-HCl with 100 mM sodium chloride (NaCl) buffers were used. To make Tris-HCl
buffer, 1.211 g of Tris-HCl was dissolved in 1 L of DI water and the pH was adjusted to
6.1 using hydrochloric acid (HCl). To make 10 mM Tris-HCl with 100 mM NaCl, 1.211 g
of Tris-HCl and 5.844 g of NaCl were dissolved in 1 L of DI water and the pH was adjusted
to 6.1.
The cell pellets were thawed in 10 mM Tris-HCl buffer at pH 6.1 and lysed using
a cell disrupter (Constant Systems, UK) shot at 20, 24, and 26 kpsi for two times each at
4°C. The cell lysates were kept on ice to minimize protease activity. The cellular debris
was removed by centrifugation (Beckman Coulter) at 13000 RPM for one hour at 4°C and
the supernatant was transferred onto a cation exchange column (Hi Trap

TM

SP HP - GE

Healthcare) with a total volume of 10 mL (two 5 mL columns were attached together). To
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remove loosely bound protein and cellular debris, the columns were washed for
approximately two hours with 10 mM Tris buffer at pH 6.1. The gradient of salt was
increased slowly using 100 mM NaCl with 10 mM Tris at pH 6.1 and the MT2a was eluted
using high performance liquid chromatography (HPLC). An ultra violet (UV)-visible
absorption spectroscopy was used to detect the MT2a. Varian, Cary 50 Bio, software was
used to detect the cadmium-thiolate ligand-to-metal charge transfer band at 250 nm to
isolate MT2a. The diluted MT2a was concentrated to 30 mL by membrane pressure
filtration with Ultracel 5 kDa ultrafiltration discs (Millipore).
Metallothionein 2a was made with an epitope tag (S-tag) at the N-terminus for
solubility and identification purposes and was cleaved off prior to the experiments using a
Thrombin Clean-Cleave Kit (Sigma-Aldrich). Preparation and regeneration of Thrombin
beads were done as per the manufacturers’ instructions. The thrombin enzyme cleaves the
peptide bond between Arg and Gly, recognizing the consensus sequence of Leu-Val-ProArg-Gly-Ser. The thrombin beads were mixed with MT2a and kept at 4°C for 12 hours.
Then, the protein mixture was diluted 10-fold to reduce the salt concentration and
transferred to the HP SP cation exchange columns. The columns were washed for 30
minutes with 10 mM Tris-HCl buffer at pH 6.1. The S-tag was eluted at low salt
concentration because it was not bound to the columns as strongly as MT2a. The MT2a
protein was eluted by increasing the salt gradient as mentioned above and then concentrated
to approximately 100 µM. Metallothionein 2a was divided into 2.5 mL aliquots and stored
at -20°C. The concentrated, purified MT2a was desalted by size exclusion chromatography
and characterized by ESI-MS (Fig. 6).
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2.1.6 Desalting and demetallation of Metallothionein 2a
A 10 mM ammonium formate (NH4HCO2) buffer was made by adding 0.631 g
formic acid, ammonium salt solid to 1 L of DI water and the pH was adjusted to 7.4 using
formic acid. The frozen MT2a aliquots were stored at -20°C were thawed in an evacuator.
A PD-10 desalting column (GE Healthcare) was used to desalt MT2a. First, the desalting
column was washed three times with deionized water at pH 1.9. Then the fourth time, 10
drops of formic acid were added to the column. 2.5 mL of MT2a was then added to the
column. To elute MT2a, 3.5 mL of deionized water at pH 1.9 was added to the column and
the eluate was collected into an Amicon Ultra-4 centrifugal filter tube (Millipore). Then 10
drops of formic acid were added to the centrifugal tube to demetallate the MT2a. The
centrifugal tube with 3.5 mL of protein solution was centrifuged for half an hour at 3900
RPM using CS6 centrifuge (Beckman Coulter) at 4°C. The tube was refilled with argon
saturated 10 mM ammonium formate buffer at 7.4 pH and then centrifuged again for 30
minutes. The last step was repeated for twice. Desalted, demetallated MT2a was transferred
to acid washed vials and capped loosely. The vial was kept in the evacuator to evacuate
oxygen, then argon saturated prior to experimentation.
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E. coli pre-cultures incubated overnight at 37°C
(100mL broth + 100µL of kanamycin(50mg/mL))
Incubation for at least 8 hours in 37°C at 1L of
LB media in the presence of 1 mL of
kanamycin (50 mg/mL) + 50 µL of 1 M CdSO4

1.

2.

After four hours of incubation, midlog phase (OD 0.6) induction of
protein expression (600 µL of 1 M
IPTG)
Metallation of half hours of
induction (150 µL of 1 M CdSO4)

Cells in liquid culture
Harvest cells

3.
4.

Isolated cells
Lyse cells

5.
6.

Supernatant
Ion exchange

Centrifugation of liquid culture (15
minutes at 6000 rpm)
Resuspension of cells (10 mM TrisHCl pH 6.1)
Cell disrupter (10 mM Tris-HCl pH 6.1
wash)
Remove cellular debris by
centrifugation (1 hour by 13000 rpm)
Eluents: 10 mM Tris-HCl pH 6.1
100 mM NaCl in 10 mM
Tris-HCl at pH 6.1

Protein solution (MT2a with S-tag)
Ion exchange

7.

Thrombin Cleavage (over night)
Eluents: 10 mM Tris-HCl pH 6.1
100 mM NaCl in 10 mM
Tris-HCl at pH 6.1

Protein solution (MT2a without S-tag)
Size exclusion purification

Eluents: 10 mM ammonium formate
pH 7.4 (for Cd7-MT2a)
DI water at pH 1.9 (for
demetalated MT2a)

Purified and desalted recombinant protein solution
(Identification and characterization by UV-visible absorption spectroscopy and
electrospray ionization mass spectrometry)

Figure 6. A flow chart of MT2a preparation; showing the overexpression, purification,
cleavage of the S-tag and demetallation of recombinant human metallothionein 2a.
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2.2 Electrospray ionization mass spectrometry measurements
All ESI mass spectra were acquired using a Bruker Micro-TOF II electrospray
ionization mass spectrometer (Bruker Daltonics, Toronto, ON) in the positive ion mode. A
10 mM NH4HCO2 buffer was used to prepare the protein solution and it served as the
electrospray carrier solvent in the positive ion mode. The mass spectrometer was calibrated
using sodium iodide (NaI). Settings: scan = 500-4000 m/z; rolling average = 2; nebulizer
= 2 bar; dry gas = 180°C @ 6.0 L/min; capillary = 4000 v; end plate offset = -500 V;
capillary exit = 175 V; Skimmer 1 = 30.0 V; Skimmer 2 = 23.5 V; Hexapole RF = 800 V.
The flow rate of the protein solution was 10 µL/min. ESI-MS spectra were recorded for
two minutes and the Maximum Entropy application of the Bruker Compass Data Analysis
software package was used to deconvolute the spectra.
2.3 Modifying metallothionein 2a with p-benzoquinone
p-Benzoquinone (Bq) is a cysteine modifier used to quantify the free cysteines in a
protein.86 Cysteine is one of the most reactive amino acids in the protein and is very prone
to post-translational modifications.86 p-Benzoquinone covalently binds to free cysteines in
MT2a, which causes a mass shift detectable using ESI-MS.
2.3.1 Benzoquinone experiment
A 100 mM Bq solution was prepared (0.1081 g of Bq mixed with 3 mL methanol
and then added to 7 mL deionized water) and covered with aluminium (Al) foil to avoid
reaction with light. Argon was bubbled into the Bq solution to displace any oxygen in the
solution. p-Benzoquinone was then added stepwise to the desalted 134 µM apo-MT2a and
the ESI-MS spectrum was recorded for two minutes. The amount of Bq in the protein
solution was increased until the amount of apo-MT2 decreased and the Bq saturated protein
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dominated. A 10 µL Tris (carboxyethyl) phosphine hydrochloride (TCEP) was added to
the protein-Bq solution to reduce disulfide bonds. TCEP stock solution was made by
dissolving six crystals of TCEP in 10 mM NH4HCO2 buffer.
2.4 Zinc titration of metallothionein 2a at low pH
A 10 mL stock solution of 50 mM zinc acetate (Zn(O2CCH3)2) was prepared by
mixing 0.1097 g of zinc acetate (Zn(CH3COO)2.2H2O) with 10 mL DI water and filtered
using a 0.2 µm syringe filter. The first experiment at low pH was conducted to find the Zn
binding pH of MT2a. A 312 µM solution of apo-MT2a was prepared and the ESI-MS
spectrum was recorded for two minutes at pH 4.1. Then 7 µL of 50 mM Zn(O2CCH3)2 was
added to the MT2a solution and the spectrum was recorded for two minutes. The pH was
changed to 4.6 and the spectrum was recorded for two minutes.
The second experiment at low pH was conducted to check whether all the Zn(II) in
the solution binds to apo-MT2a at low pH. More than 2.5 molar equivalents of Zn(II) (0.9
µ mol) was added to 312 µM apo-MT2a at pH 4.7 and recorded on the ESI-MS for two
minutes. The pH was increased to 5.2 and the spectrum was recorded for two minutes.
2.4.1 Zinc titration of metallothionein 2a at high pH
The first experiment was conducted to determine how Zn(II) binds to apo-MT2a
between pH 6 and 7. The ESI-mass spectrum for 312 µM apo-MT2a was recorded for two
minutes prior to the experiment. A 2 µL aliquot of 50 mM Zn(O2CCH3)2 was added into
the 312 µM apo-MT2a solution and the ESI mass spectrum was recorded for two minutes.
Zinc acetate was added stepwise to apo-MT2a until the Zn(II) in the protein solution
reached 2.0 molar equivalents. Each metallation step was recorded for two minutes using
ESI-MS.
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After the molar equivalents of Zn(II) reached 2.5 in the solution, the pH of the
solution was increased to 7.8 to conduct the second experiment. An ESI mass spectrum
was recorded for the solution at 7.8 then the pH was changed to 7.4, 7.1, 6.1, 5.1, 4.9, and
4.7. An ESI mass spectrum was recorded at each pH until salt adducts from the
Zn(O2CCH3)2 solution became the dominant species in the solution.
2.5 Donating zinc from holo-metallothionein 2a to apo-metallothionein 2a
To prepare Zn-MT2a, 0.9 µ mol of Zn(O2CCH3)2 was added to 312 µM apo-MT2a
at pH 7.4 and a mass spectrum of the holo-MT2a was recorded for two minutes. A 300 µL
aliquot of 134 µM apo-MT2a was added to the solution and left for two minutes for the
reaction to complete. Each ESI mass spectrum was recorded for two minutes.
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Chapter 3
Results
3.1 Human Metallothionein 2a with S-tag bound to seven cadmiums and apometallothionein 2a with S-tag
Recombinant human MT2a was made with an S-tag. Cadmium was used to induce
metal dependent protein folding of MT2a and seven Cd ions were incorporated to the
protein (Fig. 7A). The mass difference of 59 Da indicates the carboxymethylation of one
cysteine in MT2a (Fig. 7A & B). Acidification with formic acid removed Cd(II) from Cd7MT2a, resulting in apo-MT2a with an S-tag (Fig. 7B).

(A)

(B)

Figure 7. Representative ESI mass spectra of Cd7-MT2a with S-tag and apo-MT2a with
S-tag. (A) The mass of MT2a with S-tag and seven Cd (10910 m/z) and mass of
carboxymethylated MT2a with S-tag and seven Cd (10969 m/z). (B) Acidified MT2a and
carboxymethylated MT2a showing the mass difference after removal of seven Cd.
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3.1.1 Human Metallothionein 2a bound to seven cadmiums and apo-metallothionein
2a followed by removal of S-tag
The S-tag on the N-terminus of recombinant human MT2a was removed before
conducting the Zn binding studies (Fig. 8A). Thrombin enzyme cleaved the S-tag between
the Arg and Gly residues, keeping the Gly and Ser residues with the MT2a. Acidification
with formic acid removed the seven Cd(II) that were incorporated into MT2a. This resulted
in the formation of apo-MT2a and a protein mass change (Fig. 8B).

(A)

(B)

Figure 8. Representative ESI mass spectra of carboxymethylated Cd7-MT2a and apoMT2a. (A) The mass of carboxymethylated MT2a with seven Cd followed by cleavage of
S-tag (8159 m/z). (B) Acidified carboxymethylated MT2a (7387 m/z) showing the mass
difference after removal of seven Cd.
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3.2 Quantification of free cysteines in metallothionein 2a
To better understand how many of the 20 cysteines in MT2a are free thiols, studies
with the sequential addition of Bq were conducted (Fig. 9). Only 19 Bq were incorporated
into apo-MT2a, which indicates that one out of the 20 cysteines was post-translationally
modified. Addition of TCEP did not make any difference to the spectrum. If there were
disulfide bonds between cysteines (Cys-S-S-Cys), TCEP would reduce the sulfurs,
breaking the disulfide bond. There were no disulfide bonds between cysteines in apo-MT2a
and the reason why the 20th Bq molecule was not incorporated to the MT2a was likely
because a carboxymethyl group was incorporated into one of the cysteines in MT2a (Fig.
7).
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Figure 9. Representative ESI mass spectra for apo-MT2a titrated with p-benzoquinone at
pH 4.5. (A)-(F) represent of 0 µmol, 0.25 µmol, 0.5 µmol, 1 µmol, 1.2 µmol, and 1.2 µmol
of Bq in total, respectively. (F) consists of 10 µL TCEP in addition to Bq.
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3.3 Finding the metallation pH of zinc at acidic condition
Zinc was not incorporated into apo-MT2a under acidic conditions, showing that
there is no Zn (II) binding at pH 4.1 (Fig. 10B). Zinc metallation started at pH 4.6. Figure
10C shows that Zn binding follows the cooperative metal binding pathway, where the

pH
4.1

(C)
pH
4.6

Apo
1 Zn
2 Zn
3 Zn
4 Zn
5 Zn

pH
4.1

(B)

Apo

(A)

Apo

cluster formation was dominant.

Figure 10. Representative ESI mass spectra for apo-MT2 titrated with zinc acetate at pH
4.1 and 4.6. (A) 312 µM apo-MT2a with no Zn. (B) 7µL of 50 mM zinc acetate added to
apo-MT2a at pH 4.1. (C) The pH was raised to 4.6 with no change in the amount of Zn(II)
in the solution.
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3.3.1 Apo-metallothionein 2a binds relatively low zinc percent at low pH
At low pH (e.g., 4.7), only some of the Zn(II) in the solution bound to apo-MT2a
due to the acidity of the solution (Fig. 11A). When the pH of the solution was increased to
5.2, the incorporation of Zn(II) into apo-MT2a increased and no apo-MT2a was left in the
solution (Fig. 11B). The amount of Apo-MT2a, Zn1-MT2a, Zn2-MT2a and Zn3-MT2a were
reduced and Zn5-MT2a, Zn6-MT2a and Zn7-MT2a were increased when the pH shifted to
5.2. Zn4-MT2a did not show much difference (Fig. 11A & B). This shows the cooperative

7 Zn

6 Zn

5 Zn

3 Zn
4 Zn

(B)
pH
5.2

Apo
1 Zn
2 Zn

5 Zn
6 Zn

3 Zn
4 Zn

(A)
pH
4.7

Apo
1 Zn
2 Zn

nature of Zn binding.

Figure 11. Representative ESI mass spectra for Zn-MT2 at pH 4.7 and 5.2. (A) A 0.9 µmol
of zinc acetate in the solution. (B) The pH was raised to 5.2 with no change in the amount
of Zn(II) in the solution.
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3.3.2 Sequential addition of zinc to apo-metallothionein 2a between pH 6 and 7
Decreasing amounts of apo-MT2a were observed when the molar equivalents of
Zn(II) were increased stepwise between pH 6 and 7 (Fig. 12). Zinc binding to apo-MT2a
showed that non-cooperative binding pathway dominated around pH 6 and 7. Intermediates
of Zn1-MT2a, Zn2-MT2a, Zn3-MT2a and Zn5-MT2a were dominant during the titration.
Zinc speciation showed a normal distribution around Zn2-MT2a, suggestive of the beadlike structures; proposed for the non-cooperative metal binding pathway (Fig. 12D & E).
The molar equivalents of Zn(II) were calculated using the ESI mass spectral data
from Figure 12 (Fig. 13). A decrease in apo-MT2a and an increase in Zn-MT2a was
observed with the sequential addition of 0 µmol, 0.1 µmol, 0.15 µmol, 0.05 µmol, and
0.075 µmol of 50 mM Zn(O2CCH3)2 respectively (0.35 µmol total Zn(O2CCH3)2 in the
solution).
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Figure 12. Representative ESI mass spectra for apo-MT2a titrated with zinc acetate
between pH 6 and 7. A 0.1 µmol, 0.15 µmol, 0.05 µmol, and 0.075 µmol of 50 mM zinc
acetate were added to 312 µM apo-MT2a (B), (C), (D), and (E) respectively.
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Figure 13. The titration of apo-MT2a with zinc acetate. Apo-MT2a is shown in blue dots
and Zn-MT2a is shown in brown dots. Intensity of ESI mass spectral data shown in Figure
12 were used to calculate the molar equivalents of Zn(II). Order of the sequential addition
of 50 mM zinc acetate is 0 µmol, 0.1 µmol, 0.15 µmol, 0.05 µmol, and 0.075 µmol (0.35
µmol total zinc acetate in the solution).
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3.3.3 pH dependence of zinc binding to apo-metallothionein 2a starting at high pH
A 2.5 molar equivalents of Zn(II) were added to apo-MT2a prior to investigate the
pH dependence of Zn binding pathways of MT2a. Terminally bound Zn(II) was observed
at pH 7.8 (Fig. 14A), 7.4 (Fig. 14B), 7.1 (Fig. 14C), and 6.1 (Fig. 14D) while a cluster
formation dominated at pH 4.7 (Fig. 14G). Mixtures of terminally bound Zn(II) and Zn(II)
cluster formation was observed at pH 5.1 (Fig. 14E) and 4.9 (Fig. 14F). At high pH, MT2a
showed the non-cooperative metal binding pathway (Fig. 14A-D); while at low pH, MT2a
showed a more significant contribution by the cooperative metal binding pathway (Fig.
14G). To examine the pH dependence of metallation of MT2a, the pH of the same solution
was changed.
Fraction of Zn4 clusters calculated using the mass spectral data of Figure 14 and is
shown in Figure 15. (Fraction of Zn4 clusters were calculated by dividing the total intensity
of Zn4 clusters by the total intensity of Zn-MT2a). The cluster formation dominated
between pH 4.7 and 5.5 (Fig. 15).
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Figure 14. Representative of ESI mass spectra for pH titration of Zn-MT2a. The ESI-mass
spectral data were taken during the pH titration from high to low pH after adding the 2.5
molar equivalents of Zn(II).
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Figure 15. Fraction of Zn4 cluster formation as a function of pH. The cluster formation
pathway was calculated from ESI mass spectral data shown in Figure 14.

40

3.3.4 Zinc donor-accepter role of metallothionein 2a
Holo-metallothionein 2a transfers metals to apo-MT as well as apo-proteins. To
investigate this phenomenon, apo-MT2a was added to Zn-MT2a at physiological pH (7.4)
(Fig. 16B). The amount of Zn7-MT2a, Zn6-MT2a and Zn5-MT2a decreased and the amount
of Zn1-MT2a, Zn2-MT2a and Zn3-MT2a increased after addition of 300 µL of apo-MT2a
(Fig. 16B). Zinc transfer from Zn-MT2a to apo-MTa was shown. The persistence of Zn4
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Figure 16. Representative ESI mass spectra for Zn-MT2a at physiological pH 7.4. (A) ZnMT2a with no apo-MT2a. (B) The spectra of Zn-MT2a, after addition of 300 µL of 134
µM apo-MT2a.
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Chapter 4
Discussion
4.1 Difficulties in overexpression of recombinant human metallothionein 2a in E. coli
Making recombinant protein is usually attractive due to its typical low cost, high
purity and high yield. The human MT2a gene was inserted into the pET29a plasmid and
transformed into E. coli. The yield from overexpression of recombinant human MT2a
protein was low and could not be optimized using common expression techniques. Because
MT2a is made with an S-tag on the N- terminus of the recombinant human MT2a, the Nterminus is not exposed to the outside of the protein. However, the C-terminus is exposed.
Metallothionein does not have a β-pleated sheet or α-helix secondary structure like other
proteins because its protein folding is metal dependent (Fig. 4). Cadmium was added to the
medium to aid in the protein folding, expecting the cysteines to coordinate the Cd(II) in a
tetrahedral coordination. Free cysteines are very reactive, and when exposed, they can
become modified after demetallation. The primary structure of MT (without Cd) is very
prone to oxidation. Because of these reasons, MT2a yield could not be maximized using
the sequence available in the Stillman lab. Below, the S-tag is highlighted in blue and the
cysteines to be exposed in the C-terminus are highlighted in red:
MKETAAAKFERQHMDSPDLGTLVPRGSMDPNCSCAAGDSCTCAGSCKCKECKC
TSCKKSCCSCCPVGCAKCAQGCICKGASDKCSCCA

42

4.1.1 Modifying human metallothionein 2a sequence to overcome the overexpression
difficulties in E. coli
Amino acid residues (KKAAAA) were added to the C-terminus to protect the
potentially exposed cysteines. The S-tag was attached to the N-terminus, when MT2a was
made in E. coli, protecting the N-terminal cysteines. However, the S-tag was cleaved off
after purifying the protein, which exposes the N-terminal cysteines. The MT protein is
prone to oxidation when Cd(II) is removed from the N-terminus. Therefore, another set of
amino acid residues (MGKAAAA) was added to the N-terminus. Below, the S-tag is
highlighted in blue, amino acid residues in the N and C termini are highlighted in red and
green, respectively.
MKETAAAKFERQHMDSPDLGTLVPRGSMGKAAAAMDPNCSCAAGDSCTCAGS
CKCKECKCTSCKKSCCSCCPVGCAKCAQGCICKGASDKCSCCAKKAAAA
The higher alanine percent was used when modifying the MT2a sequence because
alanine is non-polar and does not carry a charge. The modifications helped to protect the
cysteines and the MT2a protein was overexpressed in large quantities in E. coli. The mass
of the MT2a protein used for the experiments was 59 Da higher than the calculated mass
of the protein due to post-translational modification of the protein (Fig. 7 & 8). Because
the mass difference of 59 Da is the same as the mass of a carboxymethyl group (59 Da), it
is possible that one of the amino acids in MT2a become post-translationally modified by
carboxymethylation.
4.1.2 Carboxymethylation of cysteines
Cysteine is one of the most reactive amino acids and is prone to post-translational
modifications.86 Proteins become oxidized when two cysteines form disulfide bonds. In
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addition, amino acids such as cysteine, lysine, methionine, tyrosine and histidine can be
modified by carboxymethylation under extreme conditions like pH, temperature and
solvent composition.87, 88 The addition of a carboxymethyl group to an amino acid yields a
modified amino acid that is somewhat similar in structure to aspartic acid.87 Therefore, the
stability of the native protein remains unchanged.89 Due to high cysteine content and
reactivity, it is thought that one of the cysteines in recombinant MT2a was posttranslationally modified by S-carboxymethylation (Fig. 17).

Cysteine

S-Carboxymethylated cysteine

Figure 17. The structures of a cysteine and a carboxymethylated cysteine. The thiol group
of a cysteine can be modified by addition of a carboxyethyl group.

4.2 Quantifying the free cysteines in recombinant human metallothionein 2a
Cysteines are involved in the metal binding by MT2a. It is therefore important to
quantify the free cysteines, which are cysteines with no disulfide bonds or no posttranslationally modified cysteines, in the protein. Quinones react with cysteines in many
biological systems.90 So, Bq was used to quantify the free cysteines in MT2a (Fig. 18) and
it was found that 19 out of 20 cysteines bound with Bq at pH 4.5 (Fig. 9). MT2a with bound
p-Bq showed a distribution of benzoquinalated species at pH 4.5 (Fig. 9D). It was revealed
that one cysteine in MT2a was post-translationally modified by S-carboxymethylation. To
break any possible disulfide bonds in MT2a, that may hinder Bq binding, the reducing
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agent TCEP was used but the result remained unchanged (Fig. 9F). It was further revealed
that MT2a was not oxidized, which means that there were no double bonds between
cysteines and one cysteine was post-translationally modified by the addition of a
carboxymethyl group.

+

p-Benzoquinone

Cysteine

Figure 18. Reaction between a p-benzoquinone and a cysteine.

4.3 Zinc binding to apo-metallothionein 2a at low pH
Very acidic environments (pH less than 3) result in demetallation of MT, due to
proton competition of the thiols, resulting in apo-MT. At pH 4.1, MT2a did not bind to
Zn(II), presumably due to the high proton content in the solution. The metallation of Zn
started at pH 4.6 (Fig. 10C) and cluster formation was dominant under these conditions.
Even though the metallation of Zn started around pH 4.6 and 4.7, not all Zn ions in the
solution were incorporated into apo-MT2, again, presumably due to the high proton
concentration. This environment caused the MT2 to exhibit cooperative binding (Fig.
11A). Moreover, MT2a contained more protonated cysteines at low pH. Shifting pH from
4.7 to 5.2 increased the Zn5-MT2a, Zn6-MT2a and Zn7-MT2 species abundance, while
lowering the amount of apo-MT2a, Zn1-MT2a, Zn2-MT2a and Zn3-MT2a (Fig. 11B).
When the pH of the solution was increased, the concentration of hydroxide ions increased,
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which reduced the acidity of the solution. This might be the reason for high Zn binding to
MT2a at higher pH.
4.3.1 Zinc binding to apo-metallothionein 2a between pH 6 and 7
Stepwise addition of Zn to apo-MT2a between pH 6 and 7 showed evidence of
bead-like structures with Zn binding to terminal thiols, which is indicative of the noncooperative metal binding pathway (Fig. 12). Several metalloforms with a normal
distribution around Zn1-MT2a were observed when the MT2a solution contained low Zn
concentrations. Then, the Zn distribution shifted over to Zn2-MT2a. Sequential addition of
approximately 2.0 molar equivalents of Zn(II) caused the amount of Zn-MT2a to increase,
while the amount of apo-MT2a decreased (Fig. 13). Apo-MT2a readily picked up the Zn(II)
between pH 6 and 7, when Zn(II) was available in the solution.
4.3.2 pH dependence of Zn binding to apo-metallothionein 2a
Zinc binding to apo-MT2a at pH 7.8 also showed evidence for the formation of
bead-like structures, which indicates non-cooperative metal binding. Under these
conditions, the Zn speciation distribution was skewed with a maximum at Zn3-MT2 at pH
7.8 (Fig. 14A). At pH 7.4 and 7.1, Zn speciation distributed normally around Zn3-MT2 and
Zn2-MT2a (Fig. 14B & C). Changing the pH from 7.1 to 6.1 showed that the dominant ZnMT2a species shifted to Zn2-MT2, whereas the non-cooperative metal binding pathway
remained unchanged (Fig. 14A-D). Cluster formation (Zn4-MT2a) was not dominant in
this metal binding pathway, showing less than 50% of the total cluster formation (Fig. 15).
At pH 5.2 and 4.9, Zn binding showed the terminally bound Zn(II) as well as cluster
formation, indicating a mixture of both binding pathways (Fig. 14E & F). This may be due
to the increase in protons in the solution as well as high protonation of cysteines. When the
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pH was changed to 4.7, cluster formation (Zn4-MT2a) dominated (Fig. 14G). Zinc clusters
are very stable because they are formed through the bridging of terminal thiols. The high
proton content in the solution may increase the binding affinity of the Zn(II) and cause the
formation of very stable clusters in a cooperative manner. This is similar to when oxygen
binds to hemoglobin in a cooperative manner, and the binding affinity is regulated by
protons, organic phosphates, chlorides and carbon dioxide.85 However, in vitro, Zn-MT2a
cluster formation is regulated by high proton content in the solution.
Irvine et al.77 showed that Cd(II) binding to MT1a at pH 6.0 formed clusters.
Conversely, in my current research, the binding of Zn(II) to MT2a showed that the
formation of bead-like structures is dominant over clusters at pH 6.1. I postulate that this
is because Cd(II) is toxic to the cell, and is sequestered more readily by MTs to form very
stable clusters. However, Zn(II) is an essential trace metal and is required for many Zn
proteins. ESI-MS showed that Zn clusters were formed less frequently at pH 6.1 and is
mostly distributive, as its ability is important for Zn(II) donation to metalloproteins.
4.3.3 Zinc donor-accepter role of human metallothionein 2a
Even though Zn binding studies were conducted at both high and low pH, it is
important to look closely at the Zn binding pattern at the physiologically relevant pH of
7.4. Several Zn-MT2a metalloforms exist at pH 7.4 (Fig. 16A). One of the most important
factors of MT is its Zn donor-accepter role in biological systems. Metallothionein donates
Zn(II) to other Zn proteins and it picks up excess Zn(II) from the cytosol, as part of the
tight control of free Zn levels in cells. After addition of apo-MT2a to the holo-MT2a at pH
7.4, the amounts of Zn5-MT2a, Zn6-MT2a and Zn7-MT2a decreased while the amounts of
Zn1-MT2a, Zn2-MT2a and Zn3-MT2a increased indicating the transfer of Zn(II) from holo-
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MT2a to apo-MT2a (Fig. 16). The clusters of four Zn bound to MT2a were very stable and
the relative amount of Zn4-MT2a remained unchanged (Fig. 16).
4.4 Importance of this research
Only a few published papers have discussed the expression of human MT2a in E.
coli91-93 but they did not conduct any metal binding studies using that protein. Also, not
very many Zn binding studies have been conducted using human MT2a. My research has
made three important discoveries:
1. At low pH (4.7), MT2a formed very stable Zn clusters.
2. At physiological pH (7.4), MT2a formed bead-like structures.
3. At physiological pH (7.4), holo-MT2a donated Zn to apo-MT2a, which confirms the
donor-acceptor role of MT2a.
My research is very important because it leads towards a better understanding of
liver MT2a and how it is similar to kidney MT1a. Also, my findings verified the wellknown phenomenon of isoforms, where the isoforms are similar proteins and perform the
same function.
4.5 Future work
The next step is to look at Cd, As and Cu binding pathways of MT2a. Then, we can
compare the metal binding mechanism of MT2a with the metal binding mechanism of
MT1a, which was examined by the Stillman group over the last few years.47,48,77,82 From
this we can determine if the metal binding of MT2a is different or similar to MT1a, even
though they are two isoforms.
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4.6 Summary and conclusion
The goal of this study was to overexpress recombinant human MT2a in E. coli in
large quantities, characterize it, and determine its Zn binding pathway. The Bq studies
showed that one out of 20 cysteines in MT2a was post-translationally modified, while the
59 Da mass shift of both the Cd7-MT2a and apo-MT2a suggested a single
carboxymethylation. In addition, donation of Zn(II) from holo-MT2a to apo-MT2a at
physiological pH (7.4) confirmed the donor-accepter role of MT to other proteins in nature.
Zinc binding studies of MT2a showed that at physiological and higher pH, MT2a
followed a non-cooperative metal binding pathway, which means that Zn binds first with
terminal thiols, making bead-like structures with no significant impact of one atom of Zn
binding affecting the affinity of the protein for other Zn atoms, before adopting a final
folded conformation. At low pH, MT2a showed cooperative metal binding, which means
that stable Zn clusters were formed through the bridging of terminal thiols. However, at
low pH, Zn binding to MT2a did not show fully cooperative (100%) manner because
intermediates of Zn1-MT2a, Zn2-MT2a, Zn3-MT2a and Zn5-MT2a were also seen in the
solution even though Zn clusters were dominant.
While previous work in the Stillman lab was carried out using kidney MT1a,47, 50,
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it was important to understand the role of the recombinant human MT2a from the liver.

Metallation properties of the two proteins are expected to be different due to the differences
in the two amino acid sequences. However, Zn binding to MT2a described in this thesis
was similar to Zn binding to MT1a that has been reported in literature,77 showing that the
two isoforms behave similarly even though their amino acid sequences are slightly
different.
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I hypothesized that metallation will differ between MT2a and MT1a due to their
sequence differences. In my current research, the Zn binding data of MT2a showed that at
low pH, Zn(II) binds cooperatively to MT2a forming stable Zn clusters and at physiological
pH, Zn(II) binds non-cooperatively to MT2a forming bead-like structures. Irvine et al.77
reported that at low pH, Zn(II) binds cooperatively to MT1a and at physiological pH, Zn(II)
binds non-cooperatively to MT1a. Therefore, I conclude that the Zn binding of MT2a is
similar to the Zn binding of MT1a. Forming bead-like structures at physiological pH, both
MT2a and MT1a can donate Zn(II) to other Zn-containing proteins and this is important to
conduct biological functions more efficiently.
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